[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fzF2VY4OmrHp0DxAYVbD1LGuAZQdZWAGLcSSze9aIlvE":8,"$fe6X6LIDDSMmw_0EPZclam7T3ccDJhybN95QeyNJ8uk0":54,"$ff3lIZ0DJpprH4pFkpWu8R6pbcuw8kIzPWphV01OgH_c":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},58070,863254,[],"https://ystcdn.venuertc.com/medical/ystApp/Dlmj9URvs7gXdepZpARivDbqwZwkg06p.png","朱永亮","龙口南山养生谷肿瘤医院","放射科","住院医师",397,0,"晚期胆管腺癌的主要用药方案及安全用药要点指南","","https://ystcdn.venuertc.com/venue/AI/e9a512c7-d9d8-4812-94d3-7e3c4d212d62.jpg","\u003Cdiv class=\"cholguide-container\">\n  \u003Ch2 id=\"material_title\" class=\"cholguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">晚期胆管腺癌的主要用药方案及安全用药要点指南\u003C/h2>\n\n  \u003Cdiv class=\"cholguide-summary\">\n    有些药物听名字陌生，但在晚期胆管腺癌的治疗中，却是患者常常会接触到的。像吉西他滨、顺铂，以及多种靶向或辅助类药物，都在临床使用中扮演了重要角色。其实，每一种药都有特别的用法和注意事项。本篇文章，将为你详细梳理7个关键细节，帮你掌握胆管腺癌主流用药的安全用药方法，规避风险，让治疗更安心。\n  \u003C/div>\n\n  \u003C!-- 1. 主要药物成分与剂型全览 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>💊\u003C/span> 主要用药成分和剂型精要\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      晚期胆管腺癌综合用药，主要包括：\n      \u003Cul>\n        \u003Cli>\u003Cstrong>吉西他滨（Gemcitabine）\u003C/strong>：注射用，属抗代谢类化疗药，常以滴注方式给药。\u003C/li>\n        \u003Cli>\u003Cstrong>顺铂（Cisplatin）\u003C/strong>：注射用，属于铂类细胞毒类化疗药，同样采用静脉滴注。\u003C/li>\n        \u003Cli>\u003Cstrong>常见靶向药物\u003C/strong>：如仑伐替尼、雷替曲韦等，通常为口服片剂。\u003C/li>\n        \u003Cli>\u003Cstrong>支持与辅助药物\u003C/strong>：地塞米松、格拉司琼等，帮助减少不良反应，常为针剂或口服液。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv>\n        \u003Cstrong>正确做法：\u003C/strong> 具体药品选择和给药方式，由临床医师和药师根据个体情况定制。患者和家属需关注药物标签上的成分及注册地址，避免混用同类药品。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 2. 药品作用原理点拨 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>🧬\u003C/span> 药品如何发挥作用？\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>吉西他滨\u003C/b>可抑制DNA和RNA的合成，从而影响细胞分裂过程。它主要对快速增殖的组织细胞起作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>顺铂\u003C/b>通过与DNA分子交联，阻断DNA复制与转录，终止细胞增殖。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>靶向药物\u003C/b>（如仑伐替尼），主要干扰肿瘤血管生成和信号通路，抑制特定分子靶点，降低化疗耐药概率。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan>\n        正确做法：关注不同药物的不同作用机制，避免逻辑混淆。配合医生计划规范用药，有助于最大化治疗收益。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 3. 正确用药时间与方法 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>⏰\u003C/span> 服药时间与正确用药方法\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cb>静脉化疗药物：\u003C/b>\u003Cbr>\n      例如吉西他滨与顺铂，均须由专业医护人员按具体剂量静脉滴注，治疗周期与间隔严格遵医嘱安排，不宜私自调整。\n      \u003Cbr>\u003Cbr>\n      \u003Cb>口服靶向药物：\u003C/b>\u003Cbr>\n      建议每日固定时间整片吞服，需用足量温水送服，不可掰碎或溶解。部分药物需空腹服用，具体依说明书为准。\n      \u003Cbr>\n      正确做法：每次用药前需认真核查药品名称、剂量和批号，遵循“六查十对”安全用药原则。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 4. 剂型与服用小技巧 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>🔬\u003C/span> 剂型特点和服用细节\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cul>\n        \u003Cli>\u003Cb>注射剂\u003C/b>不能自行注射，每次由专业护士配制并输注。\u003C/li>\n        \u003Cli>\u003Cb>口服片剂\u003C/b>必须整片吞服，避免嚼碎、研磨，以防破坏药物的吸收特性。\u003C/li>\n        \u003Cli>建议随清水吞服，避免与葡萄柚汁等饮品同服，以防影响药效。\u003C/li>\n        \u003Cli>\n          某些肠溶片如需用药，务必保留完整膜衣，一旦破损需更换。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan>\n        需要注意：如果遇到吞咽困难的老年患者，务必请药师指导换用适宜的剂型或调整剂量。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 5. 药物相互作用不可忽略 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>🚦\u003C/span> 药物相互作用与注意事项\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cb>关键点：\u003C/b>\n      \u003Cul>\n        \u003Cli>\n          吉西他滨与顺铂联合时，肾毒性与骨髓抑制风险会增加。应用期间不建议与氨基糖苷类抗生素同时使用，以免肾损伤风险上升\u003Csup>[1]\u003C/sup>。\n        \u003C/li>\n        \u003Cli>\n          服用靶向药物时，避免与含浓茶、咖啡因的饮品同服，防止刺激胃肠及影响代谢。\n        \u003C/li>\n        \u003Cli>\n          含有CYP3A4酶诱导或抑制剂的药物（如某些抗生素、抗癫痫药）可能影响靶向药物浓度和效果。\u003C/li>\n        \u003Cli>\n          日常服用维生素、补充剂时，应事先询问药师。多种膳食补充剂存在未知风险。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan>正确做法：详细记录和告知医师所有同时服用的药物。每次用药调整前需再次评估药物相互作用风险。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 6. 主要不良反应与应对 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>⚠️\u003C/span> 常见不良反应和处理方法\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      化疗药物常见不良反应有：\n      \u003Cul>\n        \u003Cli>\u003Cb>吉西他滨和顺铂\u003C/b>：骨髓抑制、恶心呕吐、肾功能异常、脱发。\u003C/li>\n        \u003Cli>\u003Cb>靶向药物\u003C/b>：可能导致高血压、皮疹、蛋白尿等。\u003C/li>\n      \u003C/ul>\n      临床数据提示，吉西他滨+顺铂方案发生严重骨髓抑制的风险，约为20%-30%\u003Csup>[1]\u003C/sup>。\n      \u003Cbr>\n      正确做法：每次化疗前需验血，监测血细胞和肾脏功能，有疑问时及时报告医生。如发生剧烈不良反应，不要擅自停药或自行处理，第一时间就医处理。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 7. 特殊人群与用药个体化 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>👨‍👩‍👦\u003C/span> 特殊人群用药调整\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>老年患者：\u003C/b> 由于肝肾功能下降，用药剂量通常会酌情下调。建议用药前后定期监测功能指标。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝肾功能不全人群：\u003C/b> 需减少相关药物用量或延长给药间隔，防止药物蓄积引发毒性反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>孕产妇及哺乳期：\u003C/b> 绝大部分化疗药与靶向药均禁用。已有用药史者应配合妇产及药师共同评估处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>合并用药：\u003C/b> 高血压患者、糖尿病患者等慢性病人群需针对性关注药物间感应与禁忌，个体化方案必不可少。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan>\n        特别提醒：有位高血压患者在使用吉西他滨和顺铂期间，严格按照医嘱调整降压药，未出现明显交互作用。此类患者要特别警惕用药联合效果，主动咨询专业药师。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 8. 储存、有效期及遗忘补救 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>📦\u003C/span> 储存条件与漏服处理\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      \u003Cb>化疗注射剂：\u003C/b>\n      应存放在2~8℃的冰箱冷藏室，不得冷冻。如需随身携带，保障环境低于25℃并避光保存。\n      \u003Cbr>\n      \u003Cb>口服靶向药物：\u003C/b>\n      存放于干燥密封、25℃以下避光处，不可放入浴室或高温潮湿环境。\n      \u003Cbr>\n      \u003Cb>漏服处理：\u003C/b>\n      如口服药物漏服1次，尽快在当天补服，时间接近下次服药时则跳过，不得一次服用双倍剂量，避免过量。\n      \u003Cbr>\n      \u003Cb>药品过期：\u003C/b>\n      超过有效期禁止继续使用，集中送交药店或医疗机构分类回收，不可随意丢弃。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 9. 实际临床用药经验分享 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>📝\u003C/span> 临床用药经验小结\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel\">\n      临床上有患者在吉西他滨+顺铂及靶向药物联合后出现骨髓抑制，经调整方案及专业处理后恢复。正确做法是，密切配合医护人员，及时反馈不适，按计划复查各项指标，远离自我调整药量的误区。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10. 总结与用药要点回顾 -->\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>🔔\u003C/span> 结语与重点提醒\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel cholguide-summary-highlight\">\n      总结一下：胆管腺癌用药过程中，化疗与靶向药品各有特点。每一步都重在细节，尤其是药物配伍、剂型选择、不良反应监测与药品储存。请牢记，规范操作和与医师药师主动沟通，是安全用药、提高疗效不可忽视的环节。如有用药疑问或遇到异常反应，第一时间就医始终是最佳方案。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"cholguide-section\">\n    \u003Cdiv class=\"cholguide-subtitle\">\n      \u003Cspan>📚\u003C/span> 参考文献\n    \u003C/div>\n    \u003Cdiv class=\"cholguide-bg-panel cholguide-ref\">\n      \u003Col>\n        \u003Cli>\n          Valle, J. W., Furuse, J., Jitlal, M., Beare, S., Mizuno, N., Wasan, H., ... & Kelley, R. K. (2014). Cisplatin and gemcitabine for biliary tract cancer: a meta-analysis of randomized trials. \u003Ci>Journal of Clinical Oncology\u003C/i>, 32(35), 3971-3981. https://doi.org/10.1200/JCO.2014.56.9659\n        \u003C/li>\n        \u003Cli>\n          Vogel, A., Bridgewater, J., Edeline, J., Kelley, R. K., Klümpen, H. J., Malka, D., ... & Valle, J. (2023). Systemic treatment of cholangiocarcinoma: current standard and future perspectives. \u003Ci>European Journal of Cancer\u003C/i>, 185, 59-77. https://doi.org/10.1016/j.ejca.2023.04.026\n        \u003C/li>\n        \u003Cli>\n          Lamarca, A., Palmer, D. H., Wasan, H. S., Ross, P. J., Ma, Y. T., Arora, A., ... & Bridgewater, J. (2020). ABC-06: A randomised phase 3, multicentre, open-label, active-controlled trial of FOLFOX chemotherapy for patients with advanced biliary tract cancer. \u003Ci>The Lancet Oncology\u003C/i>, 21(5), 699-709. https://doi.org/10.1016/S1470-2045(20)30109-1\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.cholguide-container {\n  font-family: \"Hiragino Sans GB\", \"Microsoft YaHei\", Arial, sans-serif;\n  background: #fafbfc;\n  color: #23323b;\n  padding: 36px 0 40px 0;\n  margin: 0 auto;\n  max-width: 800px;\n}\n\n.cholguide-title {\n  text-align: center;\n  font-size: 2.2em;\n  font-weight: 700;\n  margin: 12px 0 30px 0;\n  letter-spacing: 1.5px;\n  color: #246878;\n  background: linear-gradient(90deg, #e9f7fb 30%, #f2fbf9 100%);\n  border-radius: 12px;\n  padding: 20px 10px;\n  box-shadow: 0 2px 12px #dde4ec4d;\n}\n\n.cholguide-summary,\n.cholguide-summary-highlight {\n  background: #e7f2f6;\n  border-left: 6px solid #73b1c9;\n  padding: 22px 22px 18px 30px;\n  margin-bottom: 28px;\n  font-size: 1.13em;\n  border-radius: 8px;\n  line-height: 1.81;\n}\n\n.cholguide-summary-highlight {\n  background: #fff8e7;\n  border-left: 6px solid #f2bb4c;\n  color: #845e14;\n  font-weight: 600;\n}\n\n.cholguide-section {\n  margin: 30px 0;\n}\n\n.cholguide-subtitle {\n  font-size: 1.21em;\n  font-weight: bold;\n  padding: 12px 18px;\n  border-radius: 8px 8px 0 0;\n  background: linear-gradient(90deg, #f1fafd 60%, #f7ecfb 100%);\n  border-left: 7px solid #56b0bf;\n  letter-spacing: 0.5px;\n  margin-bottom: 0px;\n  display: flex;\n  align-items: center;\n  gap: 10px;\n}\n\n.cholguide-bg-panel {\n  background: linear-gradient(120deg, #fbfcfd 80%, #e7f7fc 100%);\n  border-radius: 0 0 8px 8px;\n  box-shadow: 0 1px 10px #ebedf54d;\n  padding: 23px 30px 19px 33px;\n  font-size: 1.11em;\n  line-height: 1.82;\n  word-break: break-word;\n}\n\n.cholguide-bg-panel ul {\n  margin: 0 0 10px 24px;\n  padding-left: 8px;\n  line-height: 1.7;\n}\n\n.cholguide-bg-panel li {\n  margin-bottom: 3px;\n}\n\n.cholguide-ref {\n  background: linear-gradient(120deg, #edfaf3 88%, #e3f7ff 100%);\n  border: 1px dashed #a8cfd3;\n  padding: 17px 27px 12px 25px;\n  font-size: 0.99em;\n  line-height: 1.7;\n  color: #386781;\n  border-radius: 7px;\n}\n\n@media (max-width: 900px) {\n  .cholguide-container {\n    padding: 7vw 1vw 10vw 1vw;\n    max-width: 99vw;\n  }\n  .cholguide-bg-panel, .cholguide-ref {\n    padding: 12px 5vw 15px 6vw;\n    font-size: 1em;\n  }\n}\n\u003C/style>\n\n",497,"2025-08-11 11:47:00","胆管腺癌, 化疗药物, 吉西他滨, 顺铂, 靶向药物, 用药安全, 药物不良反应, 老年患者用药","本指南详述晚期胆管腺癌的主流用药方案，涵盖吉西他滨、顺铂等药物的用法、注意事项及不良反应，帮助患者安心用药，提升治疗效果。","2025-08-24 22:22:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]